HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 608 filers reported holding HORIZON THERAPEUTICS PUB L in Q2 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $14,206,000 | -80.3% | 229,530 | -74.6% | 1.78% | -75.5% |
| Q2 2022 | $72,091,000 | -3.5% | 903,850 | +27.3% | 7.24% | +45.4% |
| Q1 2022 | $74,711,000 | -16.7% | 710,110 | -14.7% | 4.98% | +2.1% |
| Q4 2021 | $89,685,000 | -35.9% | 832,270 | -34.9% | 4.88% | -19.2% |
| Q3 2021 | $140,017,000 | +21.1% | 1,278,228 | +3.5% | 6.04% | +30.7% |
| Q2 2021 | $115,650,000 | -27.2% | 1,235,048 | -28.4% | 4.62% | -17.7% |
| Q1 2021 | $158,829,000 | -13.8% | 1,725,650 | -31.5% | 5.62% | -20.9% |
| Q4 2020 | $184,198,000 | +32.4% | 2,518,090 | +40.7% | 7.10% | +27.6% |
| Q3 2020 | $139,071,000 | +523.9% | 1,790,310 | +346.4% | 5.57% | +495.9% |
| Q2 2020 | $22,290,000 | -5.3% | 401,040 | -49.5% | 0.93% | -7.2% |
| Q1 2020 | $23,532,000 | -67.1% | 794,480 | -69.8% | 1.01% | -62.8% |
| Q3 2019 | $71,583,000 | +6.5% | 2,628,840 | -5.9% | 2.71% | +3.8% |
| Q2 2019 | $67,216,000 | – | 2,793,670 | – | 2.61% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |